IL4 and nasopharyngeal carcinoma: The last authors suggested that some help in counteracting tumour resistance to treatment in lung cancer patient could come from an IL‐4 blockade, and according to our results this adjuvant treatment could surely be of great help to overcome resistance and delay recurrence in non‐responding NPC patients.